These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9733603)

  • 1. Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS).
    Ferrer TJ; Webb JW; Wallace BH; Bridges CD; Palmer HE; Robertson RD; Cone JB
    J Surg Res; 1998 Jul; 77(2):157-64. PubMed ID: 9733603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody against tumour necrosis factor-alpha improves survival in experimental multiple organ dysfunction syndrome.
    Jansen MJ; Hendriks T; Hermsen R; Van der Meer JW; Goris RJ
    Cytokine; 1998 Nov; 10(11):904-10. PubMed ID: 9878128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 10 mitigates the development of the zymosan-induced multiple organ dysfunction syndrome in mice.
    Jansen MJ; Hendriks T; de Man BM; van der Meer JW; Goris RJ
    Cytokine; 1999 Sep; 11(9):713-21. PubMed ID: 10479408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Malleo G; Mazzon E; Genovese T; Di Paola R; Caminiti R; Esposito E; Bramanti P; Cuzzocrea S
    Cytokine; 2008 Feb; 41(2):136-43. PubMed ID: 18160304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Caminiti R; Esposito E; Di Bella P; Cuzzocrea S
    Shock; 2008 May; 29(5):560-71. PubMed ID: 17724436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of selective nitric oxide synthase blocker on survival, mesenteric blood flow and multiple organ failure induced by zymosan.
    Tanriverdi P; Yuksel BC; Rasa K; Guler G; Iskit AB; Guc MO; Korkmaz A
    J Surg Res; 2005 Mar; 124(1):67-73. PubMed ID: 15734481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of L-NG-nitroarginine in a zymosan-induced multiple organ dysfunction syndrome model.
    Ozel H; Yuksel BC; Berkem H; Avsar FM; Guler G; Iskit AB; Guc MO; Hengirmen S
    Eur Surg Res; 2009; 43(2):211-8. PubMed ID: 19556797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of elderly and adult multiple organ dysfunction syndrome in the rat model.
    Zhu Q; Qian X; Wang S; Yin T; Yang J; Xue Q; Xu B
    Exp Gerontol; 2006 Aug; 41(8):771-7. PubMed ID: 16797904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered chemokine response in an animal model of multiple organ dysfunction syndrome induced by zymosan.
    Thomas NJ; Umstead TM; Phelps DS
    J Pediatr Surg; 2005 Mar; 40(3):464-9. PubMed ID: 15793719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration.
    Ghani RA; Zainudin S; Ctkong N; Rahman AF; Wafa SR; Mohamad M; Manaf MR; Ismail R
    Nephrology (Carlton); 2006 Oct; 11(5):386-93. PubMed ID: 17014550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of matrix metalloproteinases in the murine zymosan-induced multiple organ dysfunction syndrome.
    Volman TJ; Goris RJ; Lomme RM; DeGroot J; Verhofstad AA; Hendriks T
    J Pathol; 2004 Aug; 203(4):968-75. PubMed ID: 15259001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation.
    Dimitrova P; Ivanovska N
    Int Immunopharmacol; 2008 Nov; 8(11):1567-77. PubMed ID: 18656556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of antithrombin-III on cytokines in rats with multiple organ dysfunction syndrome].
    Ren XS; Qiao YJ; Xia XH; Xu J; Jia HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):565-7. PubMed ID: 16146608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent improvements in outcome with adenoviral expression of interleukin-10 in a murine model of multisystem organ failure.
    McAuliffe PF; Murday ME; Efron PA; Scumpia PO; Ungaro R; Abouhamze A; Tannahill CL; Hutchins B; LaFace D; Moldawer LL
    Gene Ther; 2006 Feb; 13(3):276-82. PubMed ID: 16251998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GITR gene deletion and GITR-FC soluble protein administration inhibit multiple organ failure induced by zymosan.
    Galuppo M; Nocentini G; Mazzon E; Ronchetti S; Esposito E; Riccardi L; Di Paola R; Bruscoli S; Riccardi C; Cuzzocrea S
    Shock; 2011 Sep; 36(3):263-71. PubMed ID: 21654556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alteration in serum cytokines of patients with multiple organ dysfunction syndrome after liver transplantation].
    Shen ZY; Liu YH; Wang Y; Liu L; Ming Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jan; 19(1):28-30. PubMed ID: 17207361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin-6 in a non-septic shock model induced by zymosan.
    Cuzzocrea S; de Sarro G; Costantino G; Mazzon E; Laurà R; Ciriaco E; de Sarro A; Caputi AP
    Eur Cytokine Netw; 1999 Jun; 10(2):191-203. PubMed ID: 10400825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Replication of animal model and pathological study of delayed multiple organ dysfunction syndrome in mice].
    Sun Y; Lu JY; Wang XH; Hu S; Yang Y; Tong X
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Jan; 15(1):15-8. PubMed ID: 12852807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial translocation in an experimental model of multiple organ dysfunctions.
    Louis K; Netea MG; Carrer DP; Kotsaki A; Mylona V; Pistiki A; Savva A; Roditis K; Alexis A; Van der Meer JW; Giamarellos-Bourboulis EJ
    J Surg Res; 2013 Aug; 183(2):686-94. PubMed ID: 23481560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.